Abstract
Sepsis is unusual systemic reaction to an ordinary infection, and it probably represents a pattern of response by the immune system to the injury. Vitamin D is a fat-soluble steroid hormone that contributes to the maintenance of normal calcium homeostasis and skeletal mineralization. Vitamin D has an important role in the regulation of both innate and adaptive immune systems.
Aim of the Work: The current study aimed to evaluate the therapeutic value of vitamin D supplementation as an adjuvant therapy in neonates with sepsis.
Subjects and Method: This study included 60 neonates with sepsis who were randomly divided into 2 equal groups; group I: 30 neonates with sepsis who received antibiotic only, Group II: 30 neonates with sepsis who received antibiotic therapy and vitamin D. This study also included 30 healthy neonates as a control group. For all patients and controls, serum level of 25 (OH) vitamin D and highly sensitive C reactive protein (hs-CRP) were immunoassayed.
Results: There is no significant difference between groups I, II and controls regarding weight, gestational age, sex and mode of delivery. There were significant differences between groups I and II in sepsis score and hs-CRP after 3, 7, 10 days of treatment (p values for sepsis score were 0.009, 0.006, 0.004 respectively and for hs-CRP were 0.015, 0.001, 0.001 respectively). There was a significant difference in immature /total (I/T) ratio after 7, and 10 days of treatment (p value= 0.045, 0.025, respectively,) while there was no significant difference in immature /total (I/T) ratio after 3 days of treatment (p value = 0.624).Serum 25(OH) vitamin D levels were significantly lower in neonates with sepsis (group I and II) than the controls (p value < 0.05, while there were no significant differences between the three groups considering serum calcium and phosphorus levels (P =1.000, 1.000, respectively). Isolated organisms from blood culture in neonates with sepsis (group I and group II) were most commonly B- hemolytic streptococci, E-coli, hemophilus influenza and staphylococcus aurous. There was a significant negative correlation between hs-CRP and serum 25 (OH) vitamin in group II on entry (r = - 0.832 and P value = 0.001) and after 2 weeks (r = - 0.590 and P value = 0.021). ROC curve of specificity and sensitivity of 25 (OH) vitamin D level in prediction of early-onset neonatal sepsis showed that cutoff value of vitamin D was ≤20 ng/ml, sensitivity was 100%, specificity was 73%, positive predictive value was 73%, negative predictive value was 100% and accuracy was 87.
Conclusion and Recommendation: Serum 25 (OH) vitamin D levels of neonates with the early onset neonatal sepsis were significantly lower than the healthy controls. Vitamin D supplementation improved sepsis score and decrease high levels of hs-CRP; this reflects the role of vitamin D as a target therapy for neonatal sepsis. Further studies are warranted to confirm the therapeutic value of vitamin D in neonatal sepsis.
Keywords: Neonatal sepsis, vitamin D status, highly sensitive C reactive protein, adjuvant, neonates, hemophilus influenza.
[http://dx.doi.org/10.1155/2015/509484]
[PMID: 26172006]
[http://dx.doi.org/10.1586/14787210.2015.1008450] [PMID: 25661566]
[http://dx.doi.org/10.1016/j.pcl.2014.11.010] [PMID: 25836710]
[http://dx.doi.org/10.4161/derm.19859] [PMID: 22928065]
[http://dx.doi.org/10.3390/jcm7020014] [PMID: 29385701]
[http://dx.doi.org/10.1007/s12098-015-1778-3] [PMID: 25967259]
[http://dx.doi.org/10.1016/j.pedneo.2013.09.006] [PMID: 24289974]
[PMID: 26622309]
[http://dx.doi.org/10.1203/00006450-200112000-00021] [PMID: 11726736]
[PMID: 17479640]
[http://dx.doi.org/10.1053/jpan.2003.50013] [PMID: 12710004]
[http://dx.doi.org/10.1093/clinchem/46.4.461] [PMID: 10759469]
[http://dx.doi.org/10.1016/j.cca.2015.01.031]
[http://dx.doi.org/10.1136/eb-2015-102117] [PMID: 26767392]
[http://dx.doi.org/10.3109/14767058.2012.746304] [PMID: 23131172]
[http://dx.doi.org/10.1038/jp.2014.146] [PMID: 25102323]
[http://dx.doi.org/10.1111/apa.13090] [PMID: 26096884]
[http://dx.doi.org/10.1007/s00431-014-2469-1] [PMID: 25504199]
[http://dx.doi.org/10.1001/jamasurg.2013.3176] [PMID: 24284777]
[http://dx.doi.org/10.1001/jama.2014.13204] [PMID: 25268295]
[http://dx.doi.org/10.18203/2349-3291.ijcp20163168]
[http://dx.doi.org/10.1371/journal.pone.0122136] [PMID: 25849649]
[http://dx.doi.org/10.1038/pr.2015.268] [PMID: 26690713]
[http://dx.doi.org/10.3390/nu7115468] [PMID: 26569292]
[http://dx.doi.org/10.1016/j.clinbiochem.2016.01.002] [PMID: 26778547]
[http://dx.doi.org/10.3390/nu6062206] [PMID: 24918698]